Yoshikazu Fujimori

Sergliflozin, a Novel Selective Inhibitor of Low-Affinity Sodium Glucose Cotransporter (SGLT2), Validates the Critical Role of SGLT2 in Renal Glucose Reabsorption and Modulates Plasma Glucose Level

Kenji Katsuno, Yoshikazu Fujimori, Yukiko Takemura et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 266 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14

Remogliflozin Etabonate, in a Novel Category of Selective Low-Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors, Exhibits Antidiabetic Efficacy in Rodent Models

Yoshikazu Fujimori, Kenji Katsuno, Ikumi Nakashima et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 219 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Molecular Cloning and Characterization of Mouse Ficolin-A

Yoshikazu Fujimori, Satoru Harumiya, Yuki Fukumoto et al. · Biochemical and Biophysical Research Communications · 1998 · 73 citations

Life Sciences, Biochemistry, Molecular Biology +4

Sergliflozin etabonate, a selective SGLT2 inhibitor, improves glycemic control in streptozotocin-induced diabetic rats and Zucker fatty rats

Yoshikazu Fujimori, Kenji Katsuno, Kazuma Ojima et al. · European Journal of Pharmacology · 2009 · 70 citations

Medicine, Endocrinology, Pharmacology +14

Complementary ferroelectric-capacitor logic for low-power logic-in-memory VLSI

H. Kimura, Takahiro Hanyu, Michitaka Kameyama et al. · IEEE Journal of Solid-State Circuits · 2004 · 65 citations · Full text

Engineering, Computer Engineering, Electrical Engineering +17